Page results
-
UCLH has recruited the first participant for a new UK based study for Parkinson’s Disease (PD). The ASPro-PD study is testing whether treatment with a drug called ambroxol is associated with an improvement in motor and non-motor function compared with placebo.
-
Among the many cancer clinical trials opening each year at UCLH, this year will see a focus on trials of personalised cancer treatments based on precision immunotherapies.
-
The diabetes team have revisited their tips for managing diabetes over the Christmas holidays and updated them for 2022.
-
This information will give you an overview of BCG immunotherapy, how it is given and side effects it may cause.
-
The Clinical Research Facility at UCLH has been awarded £10 million in funding to deliver cutting edge early phase health research in areas including cancer and dementia.
-
North Mid, UCLH and Whittington Health are running a fun, uplifting, informative event for people with sickle cell on Saturday 25th June 2022.
-
Researchers at UCLH have begun a study which could set the foundations for how booster COVID-19 vaccinations are delivered in the future.
-
Read more about the NHS Staff Survey 2024 - we’re the top acute trust to work at for third year running!
-
UCLH has recruited the first patient in Europe for an early phase trial of a potential new medicine for patients that have a specific sub-type of multiple myeloma (MM), a type of bone marrow cancer.
-
Our staff have rated UCLH as the top trust in London to work at, and the third best in the country, during what has been another incredibly challenging year.
File results
-
FOI/2023/0683 - Electronic Patient Records (EPR)/ Patient Administration System (PAS)
-
FOI/2023/0686 - Hysteroscopy Inpatient and Outpatient pathways
-
FOI/2023/0687 - Information Governance pay grades
-
FOI/2023/0689 - Access to digital test results for patients
-
FOI/2023/0691 - Integrated medicine
-
FOI/2023/0692 - Trust's Five year strategy spend
-
FOI/2023/0696 - Freedom of Information (FOI) requests/ staff details
-
FOI/2023/0698 - Teatment of breast cancer
-
FOI/2023/0699 - Finance/ Procurement/ Estates and Facilities organisation charts
-
FOI/2023/0701 - Temporary staff spend/ waiting list initiatives and overtime Spend for 2022/23